The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010)

Thumbnail Image

Files

Smoking and breast cancer in the GS REVISED MANUSCRIPT NO TRACKING.pdf (405.39 KB)
Smoking and breast cancer in the GS REVISED TABLES NO TRACKING.pdf (330.39 KB)
Smoking and breast cancer in the GS REVISED SUPPLEMENTARY.pdf (282.21 KB)

Embargo End Date

ICR Authors

Kernaghan, Sarah
 Morden, James Peter
 Bliss, Judith
 Snowdon, Claire

Authors

Bliss, J
Kernaghan, S
Fribbens, C
Stevenson, L
Morden, J
Snowdon, C
Macpherson, I
Wardley, A
Roylance, R
Baird, R

Document Type

Other

Date

2017-05-08

Date Accepted

Abstract

Citation

TRIALS, 2017, 18 pp. ? - ? (1)

DOI

URI

https://repository.icr.ac.uk/handle/internal/873

Rights

https://www.rioxx.net/licenses/all-rights-reserved

Source Title

Publisher

BIOMED CENTRAL LTD

ISSN

1745-6215

eISSN

Collections

Clinical Studies

Research Team

Clinical Trials & Statistics Unit

Notes